Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Young women with PCOS and no other heart risk factors have normal heart function.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Finasteride helps induce ovulation in nonresponder PCOS women.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Women with different PCOS types have similar fertility treatment results.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.